Duchenne muscular dystrophy: open trials in Australia

• NCT06867107

  An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101

  Trial Treatment · Phase 2 · Satellos Bioscience, Inc.

  St Vincent Hospital, Melbourne · The Royal Children's Hospital, Melbourne

  Registry updated 2026-10-13

• NCT07587242

  A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

  Trial Treatment · Phase 3 · Avidity Biosciences, Inc.

  The Children's Hospital at Westmead, Westmead

  Registry updated 2026-10-13

• NCT07160634

  A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

  Trial Treatment · Phase 3 · Solid Biosciences Inc.

  The Children's Hospital of Westmead, Sydney

  Registry updated 2026-09-28

• NCT06066580

  Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

  Trial Treatment · Phase 2 · Edgewise Therapeutics, Inc.

  St Vincent's Hospital, Melbourne

  Registry updated 2026-09-17

All Duchenne muscular dystrophy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error